The U.S. Preventive Services Task Force recommends colorectal cancer screening for all adults starting at age 45. After age 75, the task force recommends talking with your health care team to decide ...

A new study found fecal immunochemical testing is more effective than guaiac fecal occult blood testing and is often performed at a lower cost, according to findings published by the Journal of the ...

Colorectal cancer (CRC) remains a major global health challenge, with early detection proving essential for effective treatment and improved patient outcomes. Fecal immunochemical testing (FIT) has ...

Fecal immunochemical testing, which tests for human blood in a patient’s stool, is now available as a take-home test from Life Line Screening, according to a company news release. The test requires no ...

More than 10% of fecal immunochemical test (FIT)–based colorectal cancer screening could not be processed due to unsatisfactory samples. Colorectal cancer (CRC) screening using the fecal ...

Screening annually with a method like OC-Auto FIT improves outcomes and delivers greater cost-effectiveness. Key findings from the study include: Annual FIT-based screening produced fewer CRC cases, ...

Commercially available noninvasive screening tests for colorectal cancer - a fecal immunochemical test (FIT) and the multi-target stool DNAtest (mt-sDNA; or Cologuard ®) - are equally effective for ...

Our team has compiled a comprehensive list of resources for patients, health care providers, and anyone interested in learning more about colorectal cancer. Empower yourself by increasing your ...

Colonoscopy conducted beyond 3 months and up to 24 months after a positive fecal immunochemical test are not linked to an ...

American College of Gastroenterology (ACG) gives BLUE-C study late breaker status at 2023 annual meeting with presentation of the only head-to-head study results versus FIT at ACG High specificity for ...